HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dopamine D2/3 receptor antagonism reduces activity-based anorexia.

Abstract
Anorexia nervosa (AN) is an eating disorder characterized by severe hypophagia and weight loss, and an intense fear of weight gain. Activity-based anorexia (ABA) refers to the weight loss, hypophagia and paradoxical hyperactivity that develops in rodents exposed to running wheels and restricted food access, and provides a model for aspects of AN. The atypical antipsychotic olanzapine was recently shown to reduce both AN symptoms and ABA. We examined which component of the complex pharmacological profile of olanzapine reduces ABA. Mice received 5-HT(2A/2C), 5-HT3, dopamine D1-like, D2, D3 or D2/3 antagonist treatment, and were assessed for food intake, body weight, wheel running and survival in ABA. D2/3 receptor antagonists eticlopride and amisulpride reduced weight loss and hypophagia, and increased survival during ABA. Furthermore, amisulpride produced larger reductions in weight loss and hypophagia than olanzapine. Treatment with either D3 receptor antagonist SB277011A or D2 receptor antagonist L-741,626 also increased survival. All the other treatments either had no effect or worsened ABA. Overall, selective antagonism of D2 and/or D3 receptors robustly reduces ABA. Studies investigating the mechanisms by which D2 and/or D3 receptors regulate ABA, and the efficacy for D2/3 and/or D3 antagonists to treat AN, are warranted.
AuthorsS J Klenotich, E V Ho, M S McMurray, C H Server, S C Dulawa
JournalTranslational psychiatry (Transl Psychiatry) Vol. 5 Pg. e613 (Aug 04 2015) ISSN: 2158-3188 [Electronic] United States
PMID26241351 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Dopamine D2 Receptor Antagonists
  • Indoles
  • Nitriles
  • Piperidines
  • Receptors, Dopamine D3
  • SB 277011
  • Salicylamides
  • Tetrahydroisoquinolines
  • Benzodiazepines
  • Sulpiride
  • Amisulpride
  • 3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole
  • eticlopride
  • Olanzapine
Topics
  • Amisulpride
  • Animals
  • Anorexia Nervosa (drug therapy)
  • Benzodiazepines (therapeutic use)
  • Disease Models, Animal
  • Dopamine D2 Receptor Antagonists (therapeutic use)
  • Eating (drug effects)
  • Female
  • Indoles (therapeutic use)
  • Mice
  • Mice, Inbred BALB C
  • Motor Activity (drug effects)
  • Nitriles (therapeutic use)
  • Olanzapine
  • Piperidines (therapeutic use)
  • Receptors, Dopamine D3 (antagonists & inhibitors)
  • Salicylamides (therapeutic use)
  • Sulpiride (analogs & derivatives, therapeutic use)
  • Tetrahydroisoquinolines (therapeutic use)
  • Weight Loss (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: